A new drug is hugely effective at protecting people from HIV infection and needs to be injected only twice a year.

Hopkins said that lenacapavir was expected to be reviewed by the U.S. Food and Drug Administration in 2025, with the potential to dramatically reduce HIV infection. "This will be a critical next step ...

Laredo's PILLAR received a $2.3 million grant from Texas Health, enhancing HIV and STI prevention and care through expanded ...

Health officials overseeing the city of Wuhan in China have been forced to stop HIV clinics from uploading results to a new digital system for test sharing after two HIV positive patients were refused ...

Monitoring thyroid dysfunction from HIV could prevent hypothyroidism in the few patients who have these abnormalities.

Substance Abuse and Mental Health Service’s (SAMHSA) mission is to lead public health and service delivery efforts that ...

The National AIDS, Viral Hepatitis and Sexually Transmitted Infections Control Programme (NASCP) has concluded plans to standardise procedures ...

A new law that allows minors between 14 and 17 years old to consent to the prevention of sexually transmitted diseases went ...